MELANOMA MARCH
RAISING $1 MILLION FOR WORLD-FIRST CLINICAL TRIAL
Our Co-Medical Directors join MIA’s National Ambassador Peter Overton to discuss the ground-breaking immunotherapy clinical trial and how it could transform cancer treatment globally.
LATEST NEWS
Global breakthrough in stopping melanoma spreading around body
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
A heartwarming return to Melanoma March events
Spirits were high as everyone enjoyed the return of physical Melanoma March events, and 'March Your Way' initiatives!
MIA Co-Medical Directors join Riverina Melanoma Ride
Prof Georgina Long and Prof Richard Scolyer, cycled from Albury to Wagga on Day 1 of Riverina Melanoma Ride.
MIA’s MISSION
ZERO DEATHS FROM MELANOMA
MIA will achieve its mission through 3 pillars of action: Research, Clinical Care & Education.
MIA conducts its research under 5 themes; Prevention, Early Diagnosis & Treatment, Treatment of Metastatic Disease, Survivorship & Support and Health Economics.
1300
It is estimated 1300
Australians will die from
melanoma this year
30 mins
1 Australian is diagnosed
with melanoma every 30
minutes
90%
If caught early 90% of
melanomas can be cured
by surgery
Age 20-39
Melanoma is the most
common cancer affecting
Australians aged 20 to 39
